The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes
Author
dc.contributor.author
Cea Pisani, Luis Andrés
Author
dc.contributor.author
Bevilacqua, Jorge
Author
dc.contributor.author
Arriagada Abarzúa, Christian
Author
dc.contributor.author
Cárdenas, Ana María
Author
dc.contributor.author
Bigot, Anne
Author
dc.contributor.author
Mouly, Vincent
Author
dc.contributor.author
Sáez, Juan C.
Author
dc.contributor.author
Caviedes Fernández, Pablo
Admission date
dc.date.accessioned
2017-03-02T14:25:15Z
Available date
dc.date.available
2017-03-02T14:25:15Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
BMC Cell Biology. Volumen: 17 Suplemento: 1 Número de artículo: 15
es_ES
Identifier
dc.identifier.other
10.1186/s12860-016-0096-6
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/142954
Abstract
dc.description.abstract
Background: Mutations in the gene encoding for dysferlin cause recessive autosomal muscular dystrophies called dysferlinopathies. These mutations induce several alterations in skeletal muscles, including, inflammation, increased membrane permeability and cell death. Despite the fact that the etiology of dysferlinopathies is known, the mechanism that explains the aforementioned alterations is still elusive. Therefore, we have now evaluated the potential involvement of connexin based hemichannels in the pathophysiology of dysferlinopathies.
Results: Human deltoid muscle biopsies of 5 Chilean dysferlinopathy patients exhibited the presence of muscular connexins (Cx40.1, Cx43 and Cx45). The presence of these connexins was also observed in human myotubes derived from immortalized myoblasts derived from other patients with mutated forms of dysferlin. In addition to the aforementioned connexins, these myotubes expressed functional connexin based hemichannels, evaluated by ethidium uptake assays, as opposed to myotubes obtained from a normal human muscle cell line, RCMH. This response was reproduced in a knock-down model of dysferlin, by treating RCMH cell line with small hairpin RNA specific for dysferlin (RCMH-sh Dysferlin). Also, the presence of P2X7 receptor and the transient receptor potential channel, TRPV2, another Ca2+ permeable channels, was detected in the myotubes expressing mutated dysferlin, and an elevated resting intracellular Ca2+ level was found in the latter myotubes, which was in turn reduced to control levels in the presence of the molecule D4, a selective Cx HCs inhibitor.
Conclusions: The data suggests that dysferlin deficiency, caused by mutation or downregulation of dysferlin, promotes the expression of Cx HCs. Then, the de novo expression Cx HC causes a dysregulation of intracellular free Ca2+ levels, which could underlie muscular damage associated to dysferlin mutations. This mechanism could constitute a potential therapeutical target in dysferlinopathies.